Circulating tumor DNA may be an effective biomarker for stratifying patients with small cell lung cancer who would benefit from more stringent follow-ups and clinical trial participation.Patients who ...
From vaccines and diagnostics to emerging gene-based therapies, RNA molecules are now central to modern medicine. But as ...
Synthetic Oligonucleotides are set for rapid expansion in healthcare, food production, and data storage. The technology, vital in both existing and new markets, promises vast growth potential often ...
Opportunities in the Next Generation Cancer Diagnostics Market include leveraging advancements in genomic and proteomic ...
With respect to assay development, quality assurance and, ultimately, clinical adoption, the primary subject of this review, these advantages are critical. Implicit with these advantages, TMAs enable ...
Antibiotic resistance continues to erode the effectiveness of modern medicine, creating an urgent demand for rapid and reliable diagnostic solutions. Conventional diagnostic approaches, including ...
Abstract: Microarray platforms such as Gene expression, oligonucleotide (GeneChip), and cDNA (complementary DNA) can play a critical role in the understanding of genome sequencing, by providing ...
*These authors contributed equally to the preparation of this manuscript. Cell-based technologies for printing protein microarrays are faced with poor protein expression, protein insolubility, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results